Boston Scientific has launched its new balloon dilation catheter, Coyote, to treat patients undergoing peripheral angioplasty procedures below the knee.
The Coyote Balloon Catheter is intended to help physicians when treating patients who have challenging obstructive lesions in the lower extremities.
With an ultra-low profile of 0.0174 inches, it promises to be highly deliverable and offer rapid deflation.
Balloon catheters are often used during peripheral angioplasty and stenting procedures to open blocked arteries.
J. A. Mustapha, Director of Endovascular Intervention at Metro Health Hospital in Wyoming, Michigan, said: “Its performance gives me greater confidence in being able to effectively treat patients with difficult anatomy who suffer from peripheral artery disease.”
The device is the latest in a series of balloon catheter products developed by Boston Scientific. In June, the company launched its Mustang PTA Balloon Catheter, a 0.035 inch percutaneous transluminal angioplasty (PTA) catheter designed to be used in a range of peripheral angioplasty procedures.
Jeff Mirviss, President of Boston Scientific’s Peripheral Interventions Division, said the new product launch “builds on Boston Scientific’s global leadership in low-profile peripheral balloon angioplasty”.
Up to 9 million US patients suffer from peripheral artery disease, which is associated with high rates of morbidity.
Boston Scientific has begun marketing the product in the US, Europe and other international markets.